Treatment of fibroepithelial hyperplasia (FEH) of the mammary gland in the cat with the progesterone antagonist Aglépristone (Alizine®);Der progesteronantagonist Aglépristone (Alizine®) zur behandlung der fibroepithelialen hyperplasie der mamma bei der katze

Schweizer Archiv fur Tierheilkunde

Volumn 145, Issue 3, 2003, Pages 130-136

  Meisl, D ^a   Hubler, M ^a   Arnold, S ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Agl pristone; Cat; Fibroepithelial lyperplasia; Progesterone antagonist

Indexed keywords

AGLEPRISTONE; ALIZINE; ANTIGESTAGEN; COVINAN; DELMADINON ACETATE; MEDROXYPROGESTERONE ACETATE; PROLIGESTONE; TARDEN; UNCLASSIFIED DRUG; CHLORMADINONE ACETATE; DELMADINONE; DRUG DERIVATIVE; ESTRANE DERIVATIVE; PROGESTERONE; PROGESTERONE DERIVATIVE;

ARTICLE; CAT; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; ESTRUS; FEMALE; MAMMARY GLAND; NONHUMAN; REGRESSION ANALYSIS; ULCER; ANIMAL; ANIMAL DISEASE; CAT DISEASE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; HYPERPLASIA; MALE; PATHOLOGY; TREATMENT OUTCOME; UDDER;

FELIS CATUS;

ANIMALS; CAT DISEASES; CATS; CHLORMADINONE ACETATE; ESTRENES; FEMALE; HYPERPLASIA; MALE; MAMMARY GLANDS, ANIMAL; MEDROXYPROGESTERONE 17-ACETATE; PROGESTERONE; PROGESTERONE CONGENERS; TREATMENT OUTCOME;

EID: 0037762645     PISSN: 00367281     EISSN: None     Source Type: Journal    
DOI: 10.1024/0036-7281.145.3.130     Document Type: Article

References (34)

1. Allen H. L.: Feline Mammary Hypertrophy. Vet.Path. 1973, 10: 501-508.
2. Banzhaf K., Kraus A.: Beitrag zur Fibroadenomatose (fibroepitheliale Hyperplasie) der Katze. Kleintierpraxis. 1991, 36: 367-370.
3. Baulieu E. E., Mester J.: Steroidhormone receptors. In: Endocrinology, DeGrooth L. J. ed., W. B. Saunders Company, Philadelphia, 1989, 16-39.
4. Blendinger K., Bostedt H., Hoffmann B.: Aborteinleitung und konservative Behandlung bei einer Katze unter Verwendung des Antigestagens RU 46534. Kleintierpraxis. 1994, 39: 495-499.
5. Carpenter J. L., Andrews L. K., Holzworth J.: Tumors and tumor-like lesions. In: Holzworth J.: Diseases of the cat, medicine and surgery. W. B. Saunders Company, Philadelphia, 1987, 406-596.
6. Center S. A., Randolph J. F.: Lactation and Spontaneous Remission of Feline Mammary Hyperplasia Following Pregnancy. J. Am. Anim. Hosp. Assoc. 1985, 21: 56-58.
7. Dorn A. S., Legendre A. M., McGavin M. D.: Mammary hyperplasia in a male cat receiving progesterone. J. Am. Vet. Med. Assoc. 1983, 182: 621-622.
8. Gudermuth D. F., Newton L, Daels P., Concannon P.: Incidence of spontaneous ovulation in young, group-housed cats based on serum and faecal concentrations of progesterone. J. Reprod. Fert. Suppl. 1997, 51: 177-184.
9. Hayden D. W., Johnston S. D., Kiang D. T., Johnson K. H., Barnes D. M.: Feline Mammary Hypertrophy/Fibroadenoma Complex: Clinical and Hormonal Aspects. Am. J. Vet. Res. 1981, 42: 1699-1703.
10. Hayden D. W., Johnson K. H. Ghobrial H. K.: Ultrastructure of Feline Mammary Hyperplasia. Vet. Pathol. 1983, 20: 254-264.
11. Hayden D. W. Johnson K. H.: Feline mammary hypertrophyfibroadenoma complex. In: Current Veterinary Therapy IX. ed. Kirk R. W., W. B. Saunders Company, Philadelphia, 1986, 477-480.
12. Hayden D. W., Barnes D. M., Johnson K. H.: Morphologic Changes in the Mammary Gland of Megestrol Acetate-treated and Untreated Cats: A Retrospective Study. Vet. Pathol. 1989, 26: 104-113.
13. Hecker B. R., Wehrend A., Bostedt H.: Konservative Behandlung der Pyometra bei der Katze mit dem Antigestagen Aglépristone. Kleintierpraxis. 2000, 45: 845-848.
14. Henik R. A., Olson P. N., Rosychuk R. A. W.: Progestogen Therapy in Cats. Compend. Contin. Educ. Pract. Vet. 1985, 7: 132-141.
15. Hinton Mm, Gaskell C. J.: Non-neoplastic mammary hypertrophy in the cat associated either with pregnancy or with oral progestagen therapy. Vet. Rec. 1977, 100: 277-280.
16. Johnston S. D., Hayden D. W., Kiang D. T., Handschin B., Johnson K. H.: Progesterone receptors in feline mammary adenocarcinomas. Am. J. Vet. Res. 1984, 45: 379-382.
17. Käufer I., Czernicki B.: Ein Fall von vollständiger fibroadenomatöser Veränderung der Mamma (Fibroadenomatose). Kleintierpraxis. 1982, 27: 283-286.
18. Kessler M., von Bomhard D.: Mammatumoren bei Katzen - Eine Auswertung von 2386 Fällen (1990-1995). Kleintierpraxis. 1997, 42: 459-465.
19. Lawler D. F., Johnston S. D., Hegstad R. L., Keltner D. G., Owens S. F.: Ovulation without cervical stimulation in domestic cats. J. Reprod. Fert. Suppl. 1993, 47: 57-61.
20. Mähler M., Poulsen Nautrup C., Schulze Ch.: Fibroepitheliale Hyperplasie der Mamma mit spontaner Regression bei einer Katze. Kleintierpraxis. 1994, 39: 869-875.
21. Mandel M.: Spontaneous remission of feline benign mammary hypertrophy. VM/SAC. 1975, 70: 846-847.
22. Mandelli G., Finazzi M.: Histopathologische Befunde bei dem Milchdrüsen-Hypertrophie-Fibroadenomkomplex der Katze. Dtsch. tierärztl. Wschr. 1983, 90: 482-485.
23. Martìn de las Mulas J., Millàn Y., Bautista M. J., Pérez J., Carrasco L.: Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunhistochemical study. Research in Veterinary Science. 2000, 68: 15-21.
24. Middleton D. J.: Megestrol acetate and the cat. Vet. Annu. 1986, 26: 341-347.
25. Mol J. A., van Garderen E., Selman P. J., Wolfswinkel J., Rijnberk A., Rutteman G. R.: Growth Hormone mRNA in Mammary Gland Tumors of Dogs and Cats. J. Clin. Invest. 1995, 95: 2028-2034.
26. Mol J. A., van Garderen E., Rutteman G. R., Rijnberk A.: New Insights in the Molecular Mechanism of Progestin-induced Proliferation of Mammary Epithelium: Induction of the Local Biosynthesis of Growth Hormone (GH) in the Mammary Gland of Dogs, Cats and Humans. J. Steroid. Biochem. Molec. Biol. 1996, 57: 67-71.
27. Peterson M. E.: Effects of megestrol acetate on glucose tolerance and growth hormone secretion in the cat. Research in Veterinary Science. 1987, 42: 354-357.
28. Pukay B. P., Stevenson D. A.: Mammary Hypertrophy in an Ovariohysterectomized cat. Can. Vet. J. 1983, 24: 143-144.
29. Romatowski J.: Use of megestrolacetate in cats. J. Am. Vet. Med. Assoc. 1989, 194: 700-702.
30. Seiler R. J., Kelly W. R., Menrath V. H., Barbero R. D.: Total Fibroadenomatous Change of the Mammary Glands of Two Spayed Cats. Feline Practice. 1979, 9: 25-29.
31. Ulmann A., Teutsch G., Philibert D.: La pilule de demain: une anti-hormone. Pour la Science. 1986, 100: 64-73.
32. Verstegen J. P., Onclin K., Silva L. D. M., Wouters-Ballman P., Delahaut P., Ectors F.: Regulation of progestrone during pregnancy in the cat: studies on the roles of corpora lutea, placenta and prolactin secretion. J. Reprod. Fert. Suppl. 1993, 47: 177-184.
33. Wehrend A., Bostedt H.: Die feline Fibroadenomatose. Prakt. Tierarzt. 2000, 81: 694-696.
34. Wehrend A., Hospes R., Gruber A. D.: Treatment of feline mammary fibroadenomatous hyperplasia with a progesterone-antagonist. Veterinary Record. 2001, 148: 346-347.